These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 10953310)

  • 61. [Human tumor sensitivity to 5-fluorouracil influenced by dihydropyrimidine dehydrogenase mRNA in the tumor].
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Kumai K; Kitajima M
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):274. PubMed ID: 9750075
    [No Abstract]   [Full Text] [Related]  

  • 62. Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients.
    Katona C; Kralovánszky J; Rosta A; Pandi E; Fónyad G; Tóth K; Jeney A
    Oncology; 1998; 55(5):468-74. PubMed ID: 9732227
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of 5-fluorouracil by 5-ethyl-2'-deoxyuridine on cell lines expressing different dihydropyrimidine dehydrogenase activities.
    Katona C; Tímár F; Jeney A; Fischel JL; Milano G; Pandi E; Kralovánszky J
    Anticancer Drugs; 1999 Jul; 10(6):561-7. PubMed ID: 10885904
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Dihydropyrimidine dehydrogenase and thymidylate synthase activities in colonic cancer tissue and sensitivity to 5-fluorouracil].
    Araki S; Isomoto H; Matsumoto A; Kaihara J; Yasunaga M; Hayashi K; Yatsugi H; Yamauchi K
    Nihon Geka Gakkai Zasshi; 1999 Dec; 100(12):822. PubMed ID: 10766580
    [No Abstract]   [Full Text] [Related]  

  • 65. Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to a dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS14+1g>a mutation.
    Van Kuilenburg AB; Meinsma R; Zoetekouw L; Van Gennip AH
    Int J Cancer; 2002 Sep; 101(3):253-8. PubMed ID: 12209976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The significance of dihydropyrimidine dehydrogenase (DPD) activity in bladder cancer.
    Mizutani Y; Wada H; Fukushima M; Yoshida O; Ukimura O; Kawauchi A; Miki T
    Eur J Cancer; 2001 Mar; 37(5):569-75. PubMed ID: 11290431
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of 5-fluorouracil and epidermal growth factor on cell growth and dihydropyrimidine dehydrogenase regulation in human uterine cervical carcinoma SKG-IIIb cells.
    Kashima N; Ueda M; Kanazawa J
    Cancer Sci; 2003 Sep; 94(9):821-5. PubMed ID: 12967482
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil.
    Kobuchi S; Hayashi A; Taniguchi M; Ito Y; Tamura T; Sakaeda T
    Cancer Chemother Pharmacol; 2016 Sep; 78(3):517-23. PubMed ID: 27417318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?
    Milano G; McLeod HL
    Eur J Cancer; 2000 Jan; 36(1):37-42. PubMed ID: 10741292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis.
    Zhang C; Liu H; Ma B; Song Y; Gao P; Xu Y; Yu D; Wang Z
    Dis Markers; 2017; 2017():9202676. PubMed ID: 28255193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Significance of dihydropyrimidine dehydrogenase activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Nakanishi H; Nakao M; Miki T
    Eur J Cancer; 2003 Mar; 39(4):541-7. PubMed ID: 12751387
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
    Usuki H; Ishimura K; Yachida S; Hagiike M; Okano K; Izuishi K; Karasawa Y; Goda F; Maeta H
    Gastric Cancer; 2003; 6 Suppl 1():66-70. PubMed ID: 12775023
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Recent advance in gastric cancer chemotherapy].
    Kubota T
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2043-7. PubMed ID: 11103235
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Fukushima M; Minamigawa K; Takano T; Kobayashi H
    Lung Cancer; 2001 Dec; 34(3):407-16. PubMed ID: 11714538
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics.
    Milano G; Chamorey AL
    Chronobiol Int; 2002 Jan; 19(1):177-89. PubMed ID: 11962674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer.
    Shirota Y; Ichikawa W; Uetake H; Yamada H; Nihei Z; Sugihara K
    Ann Surg Oncol; 2002 Jul; 9(6):599-603. PubMed ID: 12095978
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa.
    Miyamoto S; Ochiai A; Boku N; Ohtsu A; Tahara M; Yoshida S; Okabe H; Takechi T; Fukushima M
    Int J Oncol; 2001 Apr; 18(4):705-13. PubMed ID: 11251164
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical implications of immunoreactivity of thymidylate synthase and dihydropyrimidine dehydrogenase in gastric cancer treated with oral fluoropyrimidine (S-1). Study Group of S-1 for Gastric Cancer.
    Miyamoto S; Boku N; Ohtsu A; Yoshida S; Ochiai A; Okabe H; Fukushima M
    Int J Oncol; 2000 Oct; 17(4):653-8. PubMed ID: 10995874
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity.
    Van Kuilenburg AB; Vreken P; Beex LV; Meinsma R; Van Lenthe H; De Abreu RA; van Gennip AH
    Eur J Cancer; 1997 Nov; 33(13):2258-64. PubMed ID: 9470816
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients.
    Di Paolo A; Danesi R; Falcone A; Cionini L; Vannozzi F; Masi G; Allegrini G; Mini E; Bocci G; Conte PF; Del Tacca M
    Ann Oncol; 2001 Sep; 12(9):1301-6. PubMed ID: 11697844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.